NUAK2 and cancer: Cell lines most sensitive to GPX4 inhibitors had significantly higher NUAK2 expression compared to resistant cell lines (p < 0.00001, Student’s t-test), supporting an association across cancer types between NUAK2 and GPX4 inhibitor sensitivity.